Concepedia

Cheng-Kang Peng

CP

4

Publications

105

Citations

4

H-Index

2016

Active since

Affiliations

Jinan University(Current)

Cheng-Kang Peng is an author at Jinan University specializing in medicinal chemistry, drug discovery, and medicine.

Top concepts

Publications per year

2016–2017

4

Publications

4

Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity

Lijuan Deng, Long-Hai Wang, Cheng-Kang Peng et al. · Journal of Medicinal Chemistry · 2017 · 52 citations

Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors

Cheng-Kang Peng, Ting Zeng, Xingjun Xu et al. · European Journal of Medicinal Chemistry · 2016 · 21 citations

, , +7

Novel securinine derivatives as topoisomerase I based antitumor agents

Wen Hou, Zhenya Wang, Cheng-Kang Peng et al. · European Journal of Medicinal Chemistry · 2016 · 17 citations

, , +6

New molecular insights into the tyrosyl-tRNA synthase inhibitors: CoMFA, CoMSIA analyses and molecular docking studies

Shengrong Li, Jilin Fan, Cheng-Kang Peng et al. · Scientific Reports · 2017 · 15 citations · Full text

Rows per page

1–4 of 4